Hong Ping Yu
Net worth: 22 M $ as of 31/05/2026
Net worth: 22 M $ as of 31/05/2026
Hong Ping Yu is the founder of Abbisko Therapeutics Co., Ltd., founded in 2016, serving as Chief Scientific Officer.
Dr. Yu is the founder of Abbisko Cayman Ltd., founded in 2016, serving as Executive Director & Chief Scientific Officer.
Dr. Yu is currently Director at Abbisko Hong Kong Ltd. since 2018.
Formerly, Dr. Yu was Deputy General Manager at Hansoh Shanghai Pharmaceutical Co. Ltd. from 2011 to 2016.
Education includes a doctorate from the University of British Columbia in 2000, a graduate degree from Tsinghua University in 1994, and an undergraduate degree from Tsinghua University in 1991.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2026 | 17,612,962 ( 2.43% ) | 22 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Founder | 12/04/2016 |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Founder | 12/04/2016 |
Abbisko Hong Kong Ltd. | Director/Board Member | 01/03/2018 |
| Companies | Position | End |
|---|---|---|
Hansoh Shanghai Pharmaceutical Co. Ltd. | Corporate Officer/Principal | 01/01/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology | Health Technology |
Abbisko Cayman Ltd.
Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Abbisko Hong Kong Ltd. | |
Hansoh Shanghai Pharmaceutical Co. Ltd. |
Select your edition
All financial news and data tailored to specific country editions